July 30, 2024, Vidrio Improving Alpha Podcast
Improving Alpha: TC Wilson on Advancing the Practice of Good Medicine through Better Asset Allocation Strategies
TC Wilson, Chief Investment Officer of The Doctors Company, part of TDC Group, discusses his journey and the balancing of investments and underwriting to help generate alpha.
Search
The Malpractice Experience of Obstetricians with Shoulder Dystocia: Preparation May Mitigate Risks With This Unpredictable Event
Shoulder dystocia (SD) is a rare complication of vaginal delivery. The purpose of this study was to better understand factors that may contribute to medical malpractice claims with SD and to offer recommendations to practicing obstetricians regarding the management of SD.
The Malpractice Experience of Orthopedic Surgeons 2011 to 2021: Patient Selection and Communication May Mitigate Risk of Claims
This study analyzed 1559 closed medical malpractice claims and suits (814 ambulatory, 745 inpatient) from the loss years of 2011 to 2021 in which orthopedic surgeons were the major responsible service.
January 31, 2025, PSQH: The Podcast
PSQH: The Podcast Episode 122 – The Growing Role of Advanced Practice Clinicians
Laura Kline, MBA, CPCU, Senior Vice President of Business Development for The Doctors Company and TDC Group, discusses how nurse practitioners and physician assistants are taking on greater responsibility in primary care delivery. These expanded roles offer opportunities for all members of the healthcare delivery team to operate at the top of their licenses.
Video Aug 29, 2025
A Giant Leap: Lessons From the Early Days of Gen AI in Healthcare
Robert M. Wachter, MD, Internist; Chair, Department of Medicine, UCSF; and Member, Board of Governors, The Doctors Company, presents at the 2025 TDC Group Executive Advisory Board Meeting about how healthcare has been transformed in the early days of artificial intelligence.
An “Epidemic” of Medical Malpractice? A Commentary on the Harvard Medical Practice Study
Both supporters and opponents of malpractice legal reform can agree that the Harvard study provides us with a wealth of valuable data on questions of medical negligence. More than with most studies, however, the Harvard group’s results are subject to sharply different interpretations and depend heavily on definitions and assumptions with which many will differ.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
New York Regional Society of Plastic Surgeons Selects The Doctors Company as Exclusive Partner
The New York Regional Society of Plastic Surgeons (NYRSPS) has chosen The Doctors Company, part of TDC Group, as the exclusively endorsed medical malpractice insurer for its members.
Study of Emergency Department Diagnosis Case Type Malpractice Claims: Abstract
A study of diagnosis-type closed medical malpractice claims from care that occurred in the ED from 2014 through the second quarter of 2019 using closed coded claims from The Doctors Company.
Mar 07, 2025
Foundation Accepting Letters of Intent for 2025 Grants
The Doctors Company Foundation is currently accepting Letters of Intent for its 2025 grant cycle. Letters of Intent will be accepted through the end of business on Wednesday, March 19, 2025.
From
The Doctor’s Advocate
